USC researchers report that two blood tests, Lumipulse G p-tau217/β-Amyloid 1-42 and PrecivityAD2, can accurately detect Alzheimer’s pathology in patients with Down syndrome.
The eMTBR-Tau assay measures tau tangle pathology in blood, with potential applications in Alzheimer’s disease staging, clinical trials, and therapy monitoring.
Biomarkers in midlife adults without dementia may be linked to the earliest signs of waning cognition, researchers found.
QuidelOrtho has signed a supply agreement with Lifotronic to add multiple analyzer platforms and over 25 new immunoassays, expanding its testing portfolio in international markets outside the US.
VolitionRx reports its lateral flow prototype can detect nucleosomes in finger-prick blood samples from sepsis patients, enabling rapid, point-of-care testing outside centralized labs, according to company data.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.